World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
40492
World Ranking
2714
National Ranking
239

Overview

Susanna Dunachie is affiliated with the University of Oxford in the United Kingdom. Their research primarily spans the field of Medicine, with a specific focus on infectious diseases. The subfields of study within their work include Infectious Diseases, Immunology, Epidemiology, Molecular Biology, and Animal Science and Zoology.

The scientist's research covers key topics such as SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, vaccines and immunoinformatics approaches, immunotherapy and immune responses, animal virus infection studies, Burkholderia infections and melioidosis, and COVID-19 epidemiological studies.

Susanna Dunachie has contributed to a range of publications with notable frequent co-authors which include:

  • Paul Klenerman
  • Eleanor Barnes
  • Barbara Kronsteiner
  • Lance Turtle
  • Miles W. Carroll

Their articles have appeared in several publication venues, with repeated contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Cell
  • Nature Communications
  • Wellcome Open Research

Among the recent papers authored or co-authored by Susanna Dunachie are:

  • Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis, 2022, The Lancet
  • Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19, 2020, Nature Immunology
  • Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera, 2021, Cell
  • SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses, 2022, Cell
  • Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study, 2021, The Lancet Planetary Health

Best Publications

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

    M Voysey;Clemens Sac.;S A Madhi;L Y Weckx

  • SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

    Unknown

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.

    Y Peng;A J Mentzer;G Liu;G Liu;X Yao

  • Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

    Unknown

  • Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

    D Zhou;W Dejnirattisai;P Supasa;C Liu

  • SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

    Unknown

  • COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.

    Victoria Jane Hall;Victoria Jane Hall;Sarah Foulkes;Ayoub Saei;Nick Andrews;Nick Andrews

  • Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.

    Samuel J McConkey;William H H Reece;Vasee S Moorthy;Daniel Webster

  • SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).

    V J Hall;S Foulkes;A Charlett;A Atti

  • Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

    C Liu;H M Ginn;W Dejnirattisai;P Supasa

  • T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

    K J Ewer;Barrett;S Belij-Rammerstorfer;H Sharpe

  • The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017

    J D Stanaway;A Parisi;K Sarkar;B F Blacker

  • Antibody evasion by the P.1 strain of SARS-CoV-2.

    W Dejnirattisai;D Zhou;P Supasa;C Liu

  • A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

    Unknown

  • Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.

    P Supasa;D Zhou;W Dejnirattisai;C Liu

  • Upregulation of TGF-β, FOXP3, and CD4+CD25+ Regulatory T Cells Correlates with More Rapid Parasite Growth in Human Malaria Infection

    Michael Walther;Jon Eric Tongren;Laura Andrews;Daniel Korbel

  • Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

    M Ainsworth;M Andersson;M Andersson;K Auckland;J K Baillie

  • Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

    Daniel P. Webster;Susanna Dunachie;Jenni M. Vuola;Tamara Berthoud

  • Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.

    R P Payne;S Longet;J A Austin;D T Skelly

  • Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

    Barrett;S Belij-Rammerstorfer;C Dold;K J Ewer

  • Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

    Unknown

  • A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

    S. J. Dunachie;M. Walther;J. E. Epstein;S. Keating

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.

    J Frater;K J Ewer;A Ogbe;M Pace

  • Calculation of Liver-to-Blood Inocula, Parasite Growth Rates, and Preerythrocytic Vaccine Efficacy, from Serial Quantitative Polymerase Chain Reaction Studies of Volunteers Challenged with Malaria Sporozoites

    Philip Bejon;Laura Andrews;Rikke F. Andersen;Susanna Dunachie

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

Frequent Co-Authors

Paul Klenerman
Paul Klenerman University of Oxford
Direk Limmathurotsakul
Direk Limmathurotsakul Mahidol University
Nicholas P. J. Day
Nicholas P. J. Day University of Oxford
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Eleanor Barnes
Eleanor Barnes University of Oxford
Andrew J. Pollard
Andrew J. Pollard University of Oxford
Gavin R. Screaton
Gavin R. Screaton University of Oxford
Miles W. Carroll
Miles W. Carroll University of Oxford
John Frater
John Frater University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare fields can offer valuable career opportunities. Nursing degrees such as Licensed Practical Nurse (LPN) and Nurse Practitioner (NP) programs provide foundational and advanced clinical skills essential in healthcare settings. Many students prioritize flexibility and accessibility, making accredited LPN programs easy to get into an attractive option for starting their medical career.

As you advance, easiest NP programs to get into can help smooth the transition into more specialized nursing roles. Here, students gain expertise in patient care management and clinical decision-making relevant to immunology-related health issues.

For those passionate about mental health, pursuing a Psychiatric-Mental Health Nurse Practitioner (PMHNP) degree links immunology with psychiatric care. The top PMHNP programs are noted for excellent clinical placement rates, ensuring hands-on experience.

Cost is also a crucial factor when selecting programs. Fortunately, cheap psych NP programs offer affordable routes without compromising quality, making advanced psychiatric nursing education more accessible.

Best Scientists Citing Susanna Dunachie

Trending Scientists

Recently Published Articles